Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance oral vinorelbine versus capecitabine after first-line vinorelbine + capecitabine in metastatic breast cancer
2008-000934-35Phase 2Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Mar 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Maintenance oral vinorelbine with Maintenance capecitabine (2 arms). Primary endpoints: Progression-free survival and Event-free survival at 1 year. Started Mar 2008; status: active.
02
Drugs
vinorelbinecapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-000934-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000934-35.